// App-Quantinova.ai

568 : FAK/PYK2 inhibition enhances immune checkpoint inhibitor efficacy

Researchers

Presenter

  • Yan Wang

Principal Investigators

  • Jennifer E. Ring

  • Kam Sprott

  • David T. Weaver

  • Jonathan A. Pachter

Medical Centers

  • Verastem, Needham, MA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • Focal Adhesion Kinase

Drug/Treatment

  • VS4718

  • VS-6063

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved